Literature DB >> 488153

Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).

A Bonmassar, L Frati, M C Fioretti, L Romani, A Giampietri, A Goldin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 488153     DOI： 10.1016/0014-2964(79)90276-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

Review 1.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

2.  Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.

Authors:  P Ballerini; A Franchi; P Fuschiotti; D Piccioni; E Bonmassar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.

Authors:  Ornella Franzese; Francesco Torino; Maria Pia Fuggetta; Angelo Aquino; Mario Roselli; Enzo Bonmassar; Anna Giuliani; Stefania D'Atri
Journal:  Oncotarget       Date:  2017-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.